Oct 17, 2005
ONE STOP
Caliper Life Sciences announced an agreement to acquire NovaScreen Biosciences for $22 million, providing “one-stop-shopping for drug discovery instrumentation, and screening and assay development services,” according to Caliper.
NEW STRAND
Strand Life Sciences (formerly Strand Genomics), of Bangalore, India, launched an in silico predictive ADME/Tox tool, admetis. “admetis couples prebuilt models with a workflow-based modeling platform,” said Kas Subramanian, Strand’s CSO.
EMERGING
Pharmagene, a British human-tissue-based drug discovery company, has agreed to the terms of a merger with Asterand, a private U.S. company focused on human tissue supply and services. The directors of Pharmagene believe that the merger will create a leading company in human tissue supply and research services.
APPOINTMENT
William Emhiser was appointed CEO of Whatman, following the acquisition of Schleicher & Schuell, a German analytical chemistry supplier, which made Whatman the world’s number 3 provider of separations technology to the life sciences industry.